NIH #7R01CA160688-06
Sphingosine-1 Phosphate in Breast Cancer Progression and Lymphangiogenesis
- Amount
- $296K
- Period
- 2016-11-01 → 2018-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
Sphingolipid Metabolism and Signaling · Molecular Biology
5 total · 0 active
NIH #7R01CA160688-06
Awarded at ROSWELL PARK CANCER INSTITUTE CORP
NIH #5R01CA160688-03
Awarded at VIRGINIA COMMONWEALTH UNIVERSITY
NIH #5R01CA160688-02
Awarded at VIRGINIA COMMONWEALTH UNIVERSITY
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
RAD51 in Breast Cancer: From Vulnerability to Resistance
World Journal of Oncology · 2026-06-25
Annals of Surgical Oncology · 2026-05-28
Journal of Clinical Oncology · 2026-05-27
Research Square · 2026-05-26
World Journal of Oncology · 2026-05-08
De-Escalation of Axillary Surgery: A Review of Choosing Wisely Guideline Evidence
World Journal of Oncology · 2026-05-08
Annals of Surgical Oncology · 2026-04-30 · 1 citations
Annals of Surgical Oncology · 2026-04-28
Annals of Surgical Oncology · 2026-04-27
Cancer Research · 2026-04-17
Annals of Surgical Oncology · 2026-04-10 · 1 citations
Cancer Research · 2026-04-03
Cancer Research · 2026-04-03
Cancer Research · 2026-04-03
Cancer Research · 2026-04-03
Abstract 7947: miR-150 orchestrates immune activation and lymphocyte trafficking in breast cancer
Cancer Research · 2026-04-03
Abstract 6530: Molecular biological differences between breast and cutaneous apocrine carcinomas
Cancer Research · 2026-04-03
2026-04-02
Residual disease after neoadjuvant therapy in HER2-positive breast cancer: biology, burden, or both?
Translational Cancer Research · 2026-04-01
World Journal of Oncology · 2026-03-05